Cervista HPV HR test for cervical cancer screening: a comparative study in the Catalonian population

F Alameda, L Garrote, S Mojal… - … of Pathology and …, 2015 - meridian.allenpress.com
Context Almost all cervical cancers are related to the human papillomavirus (HPV). Future
strategies for cervical cancer screening will be based on HPV detection. The Hybrid Capture …

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3

L Kotaniemi-Talonen, A Anttila, N Malila… - European Journal of …, 2008 - Elsevier
AIM:: To determine cross-sectional validity of primary human papillomavirus (HPV)
screening in comparison to cytological screening. METHODS:: During 2003–2004, 61,149 …

Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India

R Sankaranarayanan, R Chatterji… - … journal of cancer, 2004 - Wiley Online Library
The knowledge that cervical neoplasia are caused by human papillomavirus (HPV) infection
has led to the evaluation of its role in screening. We evaluated the accuracy of HPV testing …

High-risk human papillomavirus identification in precancerous cervical intraepithelial lesions

R Zheng, DS Heller - Journal of lower genital tract disease, 2020 - journals.lww.com
Objective This review aims to summarize the currently available human papillomavirus
(HPV) testing methods for precancerous cervical intraepithelial lesions. Materials and …

Discrepant HPV/cytology cotesting results: Are there differences between cytology‐negative versus HPV‐negative cervical intraepithelial neoplasia?

JM Tracht, AD Davis, DN Fasciano… - Cancer …, 2017 - Wiley Online Library
BACKGROUND The objective of this study was to compare cervical high‐grade squamous
intraepithelial lesions subcategorized as cervical intraepithelial neoplasia‐3 (CIN‐3) …

HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study

Y Nakamura, K Matsumoto, T Satoh, K Nishide… - International journal of …, 2015 - Springer
Background In cervical cancer screening programs, women with abnormal cytology are
referred for colposcopy for histological evaluation. We examined whether a human …

[HTML][HTML] Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test

TC Wright, MH Stoler, CM Behrens, A Sharma… - Gynecologic …, 2015 - Elsevier
Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

Negative HPV testing among patients with biopsy‐proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer

E González‐Bosquet, S Fernandez… - … of Gynecology & …, 2017 - Wiley Online Library
Objective To determine the proportion of patients diagnosed with cervical cancer or cervical
intraepithelial neoplasia grade 2 or 3 (CIN 2/3) despite testing negative for HPV. Methods A …

Human papillomavirus testing versus cytology in primary cervical cancer screening: End‐of‐study and extended follow‐up results from the Canadian cervical cancer …

SD Isidean, MH Mayrand… - … journal of cancer, 2016 - Wiley Online Library
The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Glandular lesions of the cervix in clinical practice: a cytology, histology, and human papillomavirus correlation study from 2 institutions

RA Miller, DR Mody, KC Tams… - Archives of Pathology …, 2015 - meridian.allenpress.com
Context The Papanicolaou (Pap) test has indisputably decreased cervical cancer mortality,
as rates have declined by up to 80% in the United States since its implementation. However …